

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * exogenous drug catabolic process (GO:0042738) | 9.53819717 |
| 2 | * drug catabolic process (GO:0042737) | 9.02154053 |
| 3 | complement activation, alternative pathway (GO:0006957) | 8.37283148 |
| 4 | regulation of fibrinolysis (GO:0051917) | 8.10370903 |
| 5 | * epoxygenase P450 pathway (GO:0019373) | 7.95976755 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 7.95696640 |
| 7 | glyoxylate metabolic process (GO:0046487) | 7.90459524 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.74263840 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 7.74263840 |
| 10 | regulation of protein activation cascade (GO:2000257) | 7.71806436 |
| 11 | * omega-hydroxylase P450 pathway (GO:0097267) | 7.50335331 |
| 12 | regulation of complement activation (GO:0030449) | 7.24904625 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.09566343 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 7.09566343 |
| 15 | cellular glucuronidation (GO:0052695) | 6.98816602 |
| 16 | uronic acid metabolic process (GO:0006063) | 6.64644708 |
| 17 | glucuronate metabolic process (GO:0019585) | 6.64644708 |
| 18 | ethanol oxidation (GO:0006069) | 6.58296615 |
| 19 | fibrinolysis (GO:0042730) | 6.48519673 |
| 20 | * drug metabolic process (GO:0017144) | 6.27963986 |
| 21 | bile acid biosynthetic process (GO:0006699) | 6.24190775 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.14517577 |
| 23 | protein carboxylation (GO:0018214) | 6.14517577 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 5.87607863 |
| 25 | blood coagulation, intrinsic pathway (GO:0007597) | 5.81280533 |
| 26 | * urea metabolic process (GO:0019627) | 5.76459264 |
| 27 | urea cycle (GO:0000050) | 5.76459264 |
| 28 | bile acid metabolic process (GO:0008206) | 5.68753151 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 5.53782717 |
| 30 | phenylpropanoid metabolic process (GO:0009698) | 5.46097829 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.45906050 |
| 32 | negative regulation of cholesterol transport (GO:0032375) | 5.39835130 |
| 33 | negative regulation of sterol transport (GO:0032372) | 5.39835130 |
| 34 | bile acid and bile salt transport (GO:0015721) | 5.30530803 |
| 35 | ethanol metabolic process (GO:0006067) | 5.28038601 |
| 36 | * oxidative demethylation (GO:0070989) | 5.22417862 |
| 37 | * nitrogen cycle metabolic process (GO:0071941) | 5.19084158 |
| 38 | protein activation cascade (GO:0072376) | 5.06189642 |
| 39 | glycine metabolic process (GO:0006544) | 5.01188040 |
| 40 | regulation of plasminogen activation (GO:0010755) | 4.96486754 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.87165708 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 4.87165708 |
| 43 | S-adenosylmethionine metabolic process (GO:0046500) | 4.86810939 |
| 44 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.84325603 |
| 45 | complement activation (GO:0006956) | 4.80845901 |
| 46 | complement activation, classical pathway (GO:0006958) | 4.71799022 |
| 47 | alkaloid metabolic process (GO:0009820) | 4.71752031 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.61216678 |
| 49 | regulation of humoral immune response (GO:0002920) | 4.58388027 |
| 50 | imidazole-containing compound metabolic process (GO:0052803) | 4.56065939 |
| 51 | acute-phase response (GO:0006953) | 4.55841066 |
| 52 | negative regulation of protein activation cascade (GO:2000258) | 4.53057030 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.49777737 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.49777737 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.48995755 |
| 56 | negative regulation of coagulation (GO:0050819) | 4.43246154 |
| 57 | negative regulation of wound healing (GO:0061045) | 4.40622440 |
| 58 | hormone catabolic process (GO:0042447) | 4.38415583 |
| 59 | opsonization (GO:0008228) | 4.32529515 |
| 60 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.26888689 |
| 61 | flavonoid metabolic process (GO:0009812) | 4.26085617 |
| 62 | phospholipid efflux (GO:0033700) | 4.25547749 |
| 63 | tryptophan catabolic process (GO:0006569) | 4.21691440 |
| 64 | indole-containing compound catabolic process (GO:0042436) | 4.21691440 |
| 65 | indolalkylamine catabolic process (GO:0046218) | 4.21691440 |
| 66 | cytolysis (GO:0019835) | 4.19264242 |
| 67 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.19262087 |
| 68 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.19262087 |
| 69 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.18376305 |
| 70 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.15618292 |
| 71 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.15618292 |
| 72 | arginine metabolic process (GO:0006525) | 4.10301785 |
| 73 | plasma lipoprotein particle remodeling (GO:0034369) | 4.02623817 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 4.02623817 |
| 75 | macromolecular complex remodeling (GO:0034367) | 4.02623817 |
| 76 | positive regulation of blood coagulation (GO:0030194) | 4.01308073 |
| 77 | positive regulation of hemostasis (GO:1900048) | 4.01308073 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.98397353 |
| 79 | high-density lipoprotein particle remodeling (GO:0034375) | 3.97403425 |
| 80 | cholesterol efflux (GO:0033344) | 3.95851038 |
| 81 | polyketide metabolic process (GO:0030638) | 3.95352457 |
| 82 | doxorubicin metabolic process (GO:0044598) | 3.95352457 |
| 83 | daunorubicin metabolic process (GO:0044597) | 3.95352457 |
| 84 | heme transport (GO:0015886) | 3.92083061 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.89280654 |
| 86 | alpha-amino acid catabolic process (GO:1901606) | 3.88971329 |
| 87 | aromatic amino acid family metabolic process (GO:0009072) | 3.85434615 |
| 88 | intestinal cholesterol absorption (GO:0030299) | 3.83962421 |
| 89 | glutamate metabolic process (GO:0006536) | 3.83228243 |
| 90 | regulation of cholesterol esterification (GO:0010872) | 3.76256570 |
| 91 | response to mercury ion (GO:0046689) | 3.72574526 |
| 92 | positive regulation of coagulation (GO:0050820) | 3.70012048 |
| 93 | * xenobiotic metabolic process (GO:0006805) | 3.67100192 |
| 94 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.67082032 |
| 95 | negative regulation of complement activation (GO:0045916) | 3.62868154 |
| 96 | steroid catabolic process (GO:0006706) | 3.57364429 |
| 97 | cellular ketone body metabolic process (GO:0046950) | 3.56642650 |
| 98 | reverse cholesterol transport (GO:0043691) | 3.55362494 |
| 99 | sodium-independent organic anion transport (GO:0043252) | 3.54725341 |
| 100 | tryptophan metabolic process (GO:0006568) | 3.53746090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.96476291 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.73502730 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.64990533 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.58063574 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.08533299 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.63597987 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.18450398 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.14901133 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.90620004 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.21428242 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10813660 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.09514544 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.03253927 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02436174 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8778367 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.85496859 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50849020 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.48857314 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36937548 |
| 20 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29397613 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29193608 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15879535 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15310097 |
| 24 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05992495 |
| 25 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.03961120 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03226337 |
| 27 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00538038 |
| 28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98776444 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97803356 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97765548 |
| 31 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.96148690 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95849798 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94996701 |
| 34 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.93422766 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93207819 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92574817 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92493838 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91726418 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91452635 |
| 40 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.89224293 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89138607 |
| 42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88878357 |
| 43 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.87929608 |
| 44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87374679 |
| 45 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.87205121 |
| 46 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86456910 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85764665 |
| 48 | AR_20517297_ChIP-Seq_VCAP_Human | 0.84456894 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83727441 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83117818 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83045160 |
| 52 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.82529061 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82003981 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.81102553 |
| 55 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.81006516 |
| 56 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.80309726 |
| 57 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78738065 |
| 58 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.76215238 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.74225021 |
| 60 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.72924985 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.72845157 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.72277242 |
| 63 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.70386699 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.70236881 |
| 65 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.69746960 |
| 66 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.69682096 |
| 67 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.67954239 |
| 68 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.67952076 |
| 69 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.67792214 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67582543 |
| 71 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67208697 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.66976934 |
| 73 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.66357314 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66094524 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66094524 |
| 76 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.66047006 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.64709084 |
| 78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.64427077 |
| 79 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.63432430 |
| 80 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.62128663 |
| 81 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.61925036 |
| 82 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.60626369 |
| 83 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.59479123 |
| 84 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.59479123 |
| 85 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.59358054 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.59320102 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.59281298 |
| 88 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.59108930 |
| 89 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.58650445 |
| 90 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.58164780 |
| 91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.56943819 |
| 92 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.56361449 |
| 93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.55896144 |
| 94 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.55891072 |
| 95 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.55824606 |
| 96 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.55809762 |
| 97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.55725002 |
| 98 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.55289124 |
| 99 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.55153960 |
| 100 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.55060873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005085_abnormal_gallbladder_physiolo | 6.48399347 |
| 2 | MP0005360_urolithiasis | 6.13126548 |
| 3 | MP0005365_abnormal_bile_salt | 5.96666000 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.65142673 |
| 5 | MP0003195_calcinosis | 4.76258915 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.58114994 |
| 7 | MP0003252_abnormal_bile_duct | 4.44676007 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.44954232 |
| 9 | MP0003868_abnormal_feces_composition | 3.35117957 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.77176908 |
| 11 | MP0009697_abnormal_copulation | 2.71518562 |
| 12 | MP0005332_abnormal_amino_acid | 2.36279212 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.33458637 |
| 14 | MP0009840_abnormal_foam_cell | 2.24625921 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.20146734 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 10.0025658 |
| 17 | MP0002876_abnormal_thyroid_physiology | 1.97977156 |
| 18 | MP0000609_abnormal_liver_physiology | 1.86657966 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.70881163 |
| 20 | MP0001764_abnormal_homeostasis | 1.66831054 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.52235946 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.40586313 |
| 23 | MP0005670_abnormal_white_adipose | 1.26984174 |
| 24 | MP0005408_hypopigmentation | 1.16726214 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.15510271 |
| 26 | MP0009053_abnormal_anal_canal | 1.12344342 |
| 27 | MP0001661_extended_life_span | 1.12126776 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05370554 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.02273466 |
| 30 | MP0000598_abnormal_liver_morphology | 1.02144200 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.00234144 |
| 32 | MP0002132_abnormal_respiratory_system | 0.99451506 |
| 33 | MP0009764_decreased_sensitivity_to | 0.92374136 |
| 34 | MP0009763_increased_sensitivity_to | 0.85175312 |
| 35 | MP0000604_amyloidosis | 0.84514843 |
| 36 | MP0009642_abnormal_blood_homeostasis | 0.83601297 |
| 37 | MP0005376_homeostasis/metabolism_phenot | 0.81514928 |
| 38 | MP0008469_abnormal_protein_level | 0.79950993 |
| 39 | MP0002971_abnormal_brown_adipose | 0.78434065 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 0.77921059 |
| 41 | MP0003186_abnormal_redox_activity | 0.76304691 |
| 42 | MP0008872_abnormal_physiological_respon | 0.74857924 |
| 43 | MP0003011_delayed_dark_adaptation | 0.73728740 |
| 44 | MP0005451_abnormal_body_composition | 0.73471355 |
| 45 | MP0005395_other_phenotype | 0.73364383 |
| 46 | MP0005187_abnormal_penis_morphology | 0.73135415 |
| 47 | MP0005535_abnormal_body_temperature | 0.69096232 |
| 48 | MP0001915_intracranial_hemorrhage | 0.69056842 |
| 49 | MP0003879_abnormal_hair_cell | 0.66294452 |
| 50 | MP0002282_abnormal_trachea_morphology | 0.63884019 |
| 51 | MP0005266_abnormal_metabolism | 0.61681592 |
| 52 | MP0003690_abnormal_glial_cell | 0.61199038 |
| 53 | MP0005464_abnormal_platelet_physiology | 0.60262411 |
| 54 | MP0002168_other_aberrant_phenotype | 0.59355782 |
| 55 | MP0003638_abnormal_response/metabolism_ | 0.58398701 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 0.58056306 |
| 57 | MP0008874_decreased_physiological_sensi | 0.52235651 |
| 58 | MP0005334_abnormal_fat_pad | 0.51865979 |
| 59 | MP0002249_abnormal_larynx_morphology | 0.49473860 |
| 60 | MP0005023_abnormal_wound_healing | 0.48508302 |
| 61 | MP0009785_altered_susceptibility_to | 0.48004943 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 0.44569564 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.41728479 |
| 64 | MP0000249_abnormal_blood_vessel | 0.39809902 |
| 65 | MP0004130_abnormal_muscle_cell | 0.37620983 |
| 66 | MP0005166_decreased_susceptibility_to | 0.37563942 |
| 67 | MP0005448_abnormal_energy_balance | 0.37432060 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.37192264 |
| 69 | MP0003718_maternal_effect | 0.36902661 |
| 70 | MP0005164_abnormal_response_to | 0.32559750 |
| 71 | MP0005647_abnormal_sex_gland | 0.31209458 |
| 72 | MP0004883_abnormal_blood_vessel | 0.29947156 |
| 73 | MP0000467_abnormal_esophagus_morphology | 0.28302673 |
| 74 | MP0009115_abnormal_fat_cell | 0.28301854 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 0.28055782 |
| 76 | MP0002928_abnormal_bile_duct | 0.27649131 |
| 77 | MP0003953_abnormal_hormone_level | 0.27380158 |
| 78 | MP0002332_abnormal_exercise_endurance | 0.27230898 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.26944971 |
| 80 | MP0005058_abnormal_lysosome_morphology | 0.25581640 |
| 81 | MP0003075_altered_response_to | 0.25513732 |
| 82 | MP0001756_abnormal_urination | 0.25210472 |
| 83 | MP0003959_abnormal_lean_body | 0.25134434 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.24804842 |
| 85 | MP0008873_increased_physiological_sensi | 0.22567528 |
| 86 | MP0004142_abnormal_muscle_tone | 0.21681483 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.21034469 |
| 88 | MP0001851_eye_inflammation | 0.20776246 |
| 89 | MP0002970_abnormal_white_adipose | 0.17471955 |
| 90 | MP0000639_abnormal_adrenal_gland | 0.16997048 |
| 91 | MP0001881_abnormal_mammary_gland | 0.16727553 |
| 92 | MP0000920_abnormal_myelination | 0.16146073 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.15911117 |
| 94 | MP0005197_abnormal_uvea_morphology | 0.15388458 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 0.15368703 |
| 96 | MP0001545_abnormal_hematopoietic_system | 0.15368703 |
| 97 | MP0005083_abnormal_biliary_tract | 0.15359527 |
| 98 | MP0003632_abnormal_nervous_system | 0.14830873 |
| 99 | MP0002135_abnormal_kidney_morphology | 0.14299493 |
| 100 | MP0003633_abnormal_nervous_system | 0.14008063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 9.66460842 |
| 2 | Deep venous thrombosis (HP:0002625) | 9.58565419 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 8.67841953 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.02203657 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 7.92934387 |
| 6 | Abnormality of complement system (HP:0005339) | 7.83236307 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 7.44627848 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.17107647 |
| 9 | Joint hemorrhage (HP:0005261) | 5.92185179 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.62137433 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.55901123 |
| 12 | Glomerulonephritis (HP:0000099) | 5.27652325 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.85823312 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.85284627 |
| 15 | Xanthomatosis (HP:0000991) | 4.76884394 |
| 16 | Spontaneous abortion (HP:0005268) | 4.62421945 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.50318167 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.42605448 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.04062652 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.97053564 |
| 21 | Nephritis (HP:0000123) | 3.94710481 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.93558705 |
| 23 | Fat malabsorption (HP:0002630) | 3.83422874 |
| 24 | Hyperglycinemia (HP:0002154) | 3.36860608 |
| 25 | Hyperammonemia (HP:0001987) | 3.33537149 |
| 26 | Generalized aminoaciduria (HP:0002909) | 3.29654387 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.16857317 |
| 28 | Gingival bleeding (HP:0000225) | 3.12016112 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.00957549 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.00957549 |
| 31 | Steatorrhea (HP:0002570) | 2.97746952 |
| 32 | Rickets (HP:0002748) | 2.97730712 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.95409804 |
| 34 | Delayed CNS myelination (HP:0002188) | 2.87232783 |
| 35 | Hypercholesterolemia (HP:0003124) | 2.81315381 |
| 36 | Osteomalacia (HP:0002749) | 2.79450992 |
| 37 | Hyperglycinuria (HP:0003108) | 2.77804858 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 2.76651497 |
| 39 | Hyperbilirubinemia (HP:0002904) | 2.75560601 |
| 40 | Vascular calcification (HP:0004934) | 2.74438747 |
| 41 | Mitral stenosis (HP:0001718) | 2.73808465 |
| 42 | Epidermoid cyst (HP:0200040) | 2.72724285 |
| 43 | Hemorrhage of the eye (HP:0011885) | 2.69386894 |
| 44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.68910291 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 2.63026597 |
| 46 | Thrombophlebitis (HP:0004418) | 2.57632054 |
| 47 | Fair hair (HP:0002286) | 2.55107996 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.51554438 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.42189427 |
| 50 | Purpura (HP:0000979) | 2.37289145 |
| 51 | Neonatal hypoglycemia (HP:0001998) | 2.34368593 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.33246844 |
| 53 | Abnormality of vitamin metabolism (HP:0100508) | 2.32944903 |
| 54 | Pulmonary embolism (HP:0002204) | 2.28261606 |
| 55 | Reduced antithrombin III activity (HP:0001976) | 2.28084032 |
| 56 | Hyperphosphaturia (HP:0003109) | 2.25697308 |
| 57 | Abnormality of urine glucose concentration (HP:0011016) | 2.22509941 |
| 58 | Glycosuria (HP:0003076) | 2.22509941 |
| 59 | Metabolic acidosis (HP:0001942) | 2.21253360 |
| 60 | Cholelithiasis (HP:0001081) | 2.11280762 |
| 61 | Menorrhagia (HP:0000132) | 2.09185327 |
| 62 | Elevated alkaline phosphatase (HP:0003155) | 2.04678437 |
| 63 | Ketosis (HP:0001946) | 2.02487529 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.01317805 |
| 65 | Irritability (HP:0000737) | 2.00304025 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.2321065 |
| 67 | Joint swelling (HP:0001386) | 1.98873592 |
| 68 | Hydroxyprolinuria (HP:0003080) | 1.95779701 |
| 69 | Abnormality of proline metabolism (HP:0010907) | 1.95779701 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 1.94299111 |
| 71 | Cholecystitis (HP:0001082) | 1.94299111 |
| 72 | Arthropathy (HP:0003040) | 1.93291186 |
| 73 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92850836 |
| 74 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.87102286 |
| 75 | Bifid scrotum (HP:0000048) | 1.86912745 |
| 76 | Hypophosphatemic rickets (HP:0004912) | 1.85456544 |
| 77 | Poikilocytosis (HP:0004447) | 1.84560057 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 1.83259276 |
| 79 | Hypochromic microcytic anemia (HP:0004840) | 1.82020633 |
| 80 | Abnormal urine phosphate concentration (HP:0012599) | 1.81824817 |
| 81 | Abnormality of purine metabolism (HP:0004352) | 1.81027980 |
| 82 | Abnormality of the Achilles tendon (HP:0005109) | 1.79514167 |
| 83 | Generalized hypopigmentation of hair (HP:0011358) | 1.77772575 |
| 84 | Myocardial infarction (HP:0001658) | 1.77676447 |
| 85 | Increased serum ferritin (HP:0003281) | 1.75748664 |
| 86 | Increased mean platelet volume (HP:0011877) | 1.75133176 |
| 87 | Cerebral palsy (HP:0100021) | 1.73673501 |
| 88 | Bile duct proliferation (HP:0001408) | 1.73359793 |
| 89 | Abnormal biliary tract physiology (HP:0012439) | 1.73359793 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71178479 |
| 91 | Gangrene (HP:0100758) | 1.66134685 |
| 92 | Lethargy (HP:0001254) | 1.65453118 |
| 93 | Epistaxis (HP:0000421) | 1.65214227 |
| 94 | Alkalosis (HP:0001948) | 1.61569723 |
| 95 | Enlarged kidneys (HP:0000105) | 1.59671807 |
| 96 | Abnormal platelet volume (HP:0011876) | 1.57450408 |
| 97 | Skin nodule (HP:0200036) | 1.56643088 |
| 98 | Pancreatitis (HP:0001733) | 1.55717012 |
| 99 | Proximal tubulopathy (HP:0000114) | 1.55295652 |
| 100 | Gout (HP:0001997) | 1.53527834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.78098481 |
| 2 | PIK3CG | 4.40098212 |
| 3 | FGFR4 | 3.25079306 |
| 4 | RIPK1 | 2.92983543 |
| 5 | FRK | 2.81344258 |
| 6 | TYK2 | 2.64096074 |
| 7 | EPHA3 | 2.44678446 |
| 8 | PIK3CA | 2.43641600 |
| 9 | PRKACG | 2.32418349 |
| 10 | NTRK3 | 2.19466052 |
| 11 | MST1R | 2.19431928 |
| 12 | BCKDK | 2.12174400 |
| 13 | PRKAA2 | 1.90300467 |
| 14 | SIK1 | 1.87050170 |
| 15 | MAP3K3 | 1.68221561 |
| 16 | FER | 1.66991365 |
| 17 | MAPK11 | 1.66854474 |
| 18 | MAP2K4 | 1.66152625 |
| 19 | ACVR1B | 1.61422508 |
| 20 | TAOK3 | 1.60322201 |
| 21 | FGFR3 | 1.59201008 |
| 22 | TNK2 | 1.56922877 |
| 23 | PRKCG | 1.54020571 |
| 24 | IGF1R | 1.43156927 |
| 25 | TRIB3 | 1.40324382 |
| 26 | MAP3K12 | 1.40287750 |
| 27 | PINK1 | 1.39277294 |
| 28 | TBK1 | 1.38215831 |
| 29 | NEK9 | 1.34569791 |
| 30 | ABL2 | 1.33092615 |
| 31 | JAK1 | 1.29738375 |
| 32 | MAP3K2 | 1.29473397 |
| 33 | EPHA4 | 1.27471718 |
| 34 | NLK | 1.27196341 |
| 35 | PRPF4B | 1.26209475 |
| 36 | MYLK | 1.21252146 |
| 37 | PDPK1 | 1.17722800 |
| 38 | CAMKK2 | 1.16632965 |
| 39 | INSRR | 1.13496235 |
| 40 | PRKCZ | 1.11431997 |
| 41 | ERBB2 | 1.09854059 |
| 42 | PRKG1 | 1.02909654 |
| 43 | AKT3 | 1.02892033 |
| 44 | LMTK2 | 1.01913490 |
| 45 | JAK2 | 1.00155369 |
| 46 | PRKACA | 0.94288710 |
| 47 | PRKAA1 | 0.94069044 |
| 48 | DAPK2 | 0.93627207 |
| 49 | MET | 0.92220958 |
| 50 | EPHB1 | 0.90915008 |
| 51 | WNK3 | 0.90468301 |
| 52 | PDK1 | 0.86867478 |
| 53 | GRK1 | 0.84338592 |
| 54 | IRAK3 | 0.83538658 |
| 55 | MAP4K2 | 0.83276931 |
| 56 | BCR | 0.79876765 |
| 57 | MAP3K1 | 0.77260485 |
| 58 | PRKCA | 0.73412384 |
| 59 | RET | 0.69405254 |
| 60 | PRKCB | 0.67793210 |
| 61 | CSF1R | 0.66773822 |
| 62 | CSNK1D | 0.66267353 |
| 63 | PDK2 | 0.66008769 |
| 64 | TIE1 | 0.64320045 |
| 65 | PRKG2 | 0.59592135 |
| 66 | CDK6 | 0.57829438 |
| 67 | KDR | 0.57443614 |
| 68 | MAP3K6 | 0.56531914 |
| 69 | ZAP70 | 0.56301763 |
| 70 | RPS6KA3 | 0.53295871 |
| 71 | CASK | 0.52768488 |
| 72 | ERBB4 | 0.52619580 |
| 73 | PRKACB | 0.50848781 |
| 74 | SRC | 0.49547536 |
| 75 | PRKCE | 0.49476283 |
| 76 | MAPK7 | 0.49214351 |
| 77 | MAP3K5 | 0.47817491 |
| 78 | CSNK1E | 0.46189793 |
| 79 | MAPKAPK3 | 0.45680953 |
| 80 | PAK3 | 0.44999868 |
| 81 | MAPK4 | 0.41838696 |
| 82 | CAMK2G | 0.40574130 |
| 83 | MUSK | 0.40387538 |
| 84 | TGFBR2 | 0.40176932 |
| 85 | ICK | 0.39723948 |
| 86 | PKN2 | 0.39194127 |
| 87 | SGK1 | 0.38679080 |
| 88 | CSNK1A1 | 0.38409564 |
| 89 | MAP3K7 | 0.38271082 |
| 90 | SCYL2 | 0.37372502 |
| 91 | MAP3K11 | 0.37340320 |
| 92 | GSK3A | 0.36483274 |
| 93 | PTK6 | 0.36233687 |
| 94 | SGK2 | 0.36021648 |
| 95 | DYRK1B | 0.35059363 |
| 96 | STK38 | 0.34458894 |
| 97 | SGK494 | 0.33497215 |
| 98 | SGK223 | 0.33497215 |
| 99 | SGK3 | 0.32637787 |
| 100 | BLK | 0.32611893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.59126718 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.03122846 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.96360128 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.72762151 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.65901269 |
| 6 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.41915939 |
| 7 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.38068731 |
| 8 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.90199112 |
| 9 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.87653621 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.82590366 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.75236276 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.74251682 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55392068 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.42832862 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41354016 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.33919267 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.20206361 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11719657 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03790855 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92260949 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90594476 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.89383344 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.86488501 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.64779045 |
| 25 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.58641194 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57405336 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56818230 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.39189744 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36765954 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.29734973 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.28094522 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26441784 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26341854 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24398359 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23640156 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20584906 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19405649 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.10335152 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01408292 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99898887 |
| 41 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98285548 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98136158 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93250613 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92503878 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92226479 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.84295844 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81848752 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81615423 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81513607 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79343402 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76649426 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75211216 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68370187 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67104644 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61888943 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.48860628 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48773082 |
| 58 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.41593513 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34697169 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34030434 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32725501 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29456712 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.28357028 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24691859 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22224262 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.20772579 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.20584513 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15954718 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11471688 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11050017 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09153046 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08855834 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.08380939 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.07849816 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.07473367 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07247774 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04694432 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03254338 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.02727694 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.01532868 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2579647 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2578664 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2399591 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2269650 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2176485 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2172219 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1932860 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1889368 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1783569 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1672186 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1482305 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1265826 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1086905 |
| 94 | * Serotonergic synapse_Homo sapiens_hsa04726 | -0.0824710 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0798893 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | -0.0582645 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0552634 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0232790 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0164852 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0088756 |

